NCT05646875

Brief Summary

In this prospective pilot study, the effects of hyperbaric oxygen therapy (HBOT) in post-cardiac arrest syndrome will be evaluated. However, the primary outcome of this pilot study will be the feasibility of this approach. If feasibility is determined, a larger study with adequate powering is to follow.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 13, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

November 22, 2022

Last Update Submit

December 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the study approach

    Successfully recruiting at least 10 patients in each of the 3 study arms

    8 months

Secondary Outcomes (1)

  • Inflammation dynamics

    around 7 days (individual patient) / 8 months (study duration)

Study Arms (3)

post-ROSC

EXPERIMENTAL

patients directly post-ROSC receiving HBOT

Other: hyperbaric oxygen therapy

cardiac arrest survivors discharged home receiving HBOT

ACTIVE COMPARATOR

cardiac arrest survivors discharged home

Other: hyperbaric oxygen therapy

healthy volunteers receiving HBOT

ACTIVE COMPARATOR

healthy volunteers receiving HBOT

Other: hyperbaric oxygen therapy

Interventions

Hyperbaric oxygen therapy in a pressurized chamber, duration 1-2 hours at 2-3 ATA

cardiac arrest survivors discharged home receiving HBOThealthy volunteers receiving HBOTpost-ROSC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Healthy volunteers:
  • CA survivors after hospital discharge:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Edegem, 2650, Belgium

Location

MeSH Terms

Conditions

Heart ArrestBrain Injuries

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Officials

  • Koen Monsieurs, Prof., MD

    University Hospital of Antwerp, Belgium

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 3 groups: 1) post-ROSC patients 2) cardiac arrest survivors already discharged 3) healthy volunteers
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Koen Monsieurs, MD

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 12, 2022

Study Start

February 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 13, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations